0001562180-15-001101.txt : 20151217
0001562180-15-001101.hdr.sgml : 20151217
20151217160158
ACCESSION NUMBER: 0001562180-15-001101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151215
FILED AS OF DATE: 20151217
DATE AS OF CHANGE: 20151217
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tokai Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 255 STATE STREET
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 617-225-4348
MAIL ADDRESS:
STREET 1: 255 STATE STREET
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kalowski Lee
CENTRAL INDEX KEY: 0001618273
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 151293643
MAIL ADDRESS:
STREET 1: C/O TOKAI PHARMACEUTICALS, INC.
STREET 2: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2015-12-15
false
0001404281
Tokai Pharmaceuticals Inc
TKAI
0001618273
Kalowski Lee
C/O TOKAI PHARMACEUTICALS, INC.
255 STATE STREET 6TH FLOOR
BOSTON
MA
02109
false
true
false
false
Chief Financial Officer
Stock Option (right to buy)
9.65
2015-12-15
4
A
false
62000.00
0.00
A
2025-12-14
Common Stock
62000.00
62000.00
D
This option vests with respect to 12.5% of the shares underlying the option vesting on June 30, 2016 and an additional 2.0833% on the last day of each month thereafter through December 31, 2019.
/s/ Cindy Driscoll, Attorney-in-Fact
2015-12-17